Molecular genetic studies of familial hypertrophic cardiomyopathy

Basic Research in Cardiology, Supplement

Volumn 93, Issue 3, 1998, Pages 13-16

  Seidman, C E ^a   Seidman, J G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR GENETICS; MOUSE; NONHUMAN; SHORT SURVEY;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; MUTATION; TROPONIN T;

EID: 0032428460     PISSN: 01759418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Bonne G, Carrier L, Bercovici J et al. (1995) Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophie cardiomyopathy. Nature Genet 11: 438-440
2. Coviello DA, Maron BJ, Spirito P, Watkins H, Vosberg H-P, Theirfelder L, Schoen FJ, Seidman JG, Seidman CE (1997) Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the α tropomyosin gene. JACC (in press)
3. Frank S, Braunwald E (1968) Idiopathic hypertrophic subaortic stenosis: Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37: 759-88
4. Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction? EMBO 14: 1952-1960
5. Geisterfer-Lowrance AAT, Christe M, Conner DA, Ingwall JS, Schoen RJ, Seidman CE, Seidman JG (1996) A murine model of familial hypertrophie cardiomyopathy. Science 272: 731-734
6. MacRae C, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins H, Anan R, Theirfelder LH, McGarry K, Rowland E, McKenna W, Seidman JG, Seidman CE (1995) Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White Syndrome maps to a locus on chromosome 7q3. J Clin Invest 96: 1216-1220
7. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316: 780-9 and 844-52
8. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92: 785-9
9. McKenna WJ, Deanfield J, Faruqui A, England D, Oakley CM, Goodwin JF (1981) Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic, and hemodynamic features. Am J Cardiol 47: 532-8
10. Moos C, Feng IM (1980) Effect of C-protein on actomyosin ATPase. Biochim Biophys Acta 632: 141-149
11. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Dananapazir L, Epstein ND (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet 13: 63-69
12. Schlender K, Bean LJ (1991) Phosphorylation of chick cardiac C-protein by calcium/calmodulin-dependent protein kinase II. J Biol Chem 266: 2811-2817
13. Solomon S, Jarcho JA, McKenna W, Geisterfer-Lowrance A, Germain R, Salerni R, Seidman JG, Seidman CE (1990) Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 86: 993-999
14. Solomon SD, Wolff S, Watkins H et al. (1993) Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 22:498-505
15. Spirito P, Chiarella F, Carratino L, ZoniBerisso M, Bellotti P, Vecchio C (1989) Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 320: 749-55
16. Thierfelder L, Watkins H, MacRae C, Lumas R, McKenna W, Vosberg H-P, Seidman JG, Seidman CE (1994) α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 77: 701-712
17. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE (1995) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet 11: 434-437
18. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE (1995) Mutations in the genes for cardiac troponin T and a tropomyosin mutations in hypertrophic cardiomyopathy. N Engl J Med 332: 1058-1064
19. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108-1114
20. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL (1997) Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy: evidence for a dominant negative action. J Clin Invest (in press)